Prothena | PRTA - Créances Commerciales





Créances Commerciales Changement Date
Acadia Pharmaceuticals USD 148.38M 153K 2026-03
Agios Pharmaceuticals USD 16.13M 5.56M 2026-03
Akebia Therapeutics USD 47.03M 19.19M 2025-12
ALKERMES USD 456.48M 48.85M 2026-06
Alnylam Pharmaceuticals USD 912.74M 28.78M 2026-06
Amgen USD 9.14B 432M 2026-03
Biogen USD 1.79B 76.6M 2026-03
BioMarin Pharmaceutical USD 903.91M 4.3M 2026-03
Exelixis USD 328.95M 42.03M 2026-03
Immunic USD 333K 156K 2025-12
Incyte USD 1.13B 73.7M 2026-06
Ionis Pharmaceuticals USD 58.84M 15.16M 2026-06
MacroGenics USD 10.42M 2.95M 2026-03
Nektar Therapeutics USD 1.78M 1.12M 2025-12
Neurocrine Biosciences USD 887M 118.9M 2026-06
Prothena USD 5.16M 0 2023-12
Regeneron Pharmaceuticals USD 6.57B 834.4M 2026-06
Ultragenyx Pharmaceutical USD 60M 98M 2026-03
Vertex Pharmaceuticals USD 2B 56.7M 2026-03